Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2006;114:1531-1544
doi: 10.1161/CIRCULATIONAHA.105.605519
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zimmet, J. M.
Right arrow Articles by Hare, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zimmet, J. M.
Right arrow Articles by Hare, J. M.
Related Collections
Right arrow Congestive
Right arrow Cell signalling/signal transduction
Right arrow Heart failure - basic studies
Right arrow Oxidant stress
Right arrow Endothelium/vascular type/nitric oxide

(Circulation. 2006;114:1531-1544.)
© 2006 American Heart Association, Inc.


Basic Science for Clinicians

Nitroso–Redox Interactions in the Cardiovascular System

Jeffrey M. Zimmet, MD; Joshua M. Hare, MD

From the Department of Medicine, Division of Cardiology, Institute for Cell Engineering, and Johns Hopkins University School of Medicine, Baltimore, Md.

Correspondence to Joshua M. Hare, MD, Johns Hopkins Medical Institutions and Institute for Cell Engineering, Division of Cardiology, BRB 651, 733 N Broadway, Baltimore, MD 21205. E-mail jhare@mail.jhmi.edu


Key Words: antioxidants • heart failure • nitric oxide • nitric oxide synthase • oxygen


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 


*    Introduction
 
Normal cardiovascular performance requires exquisite balancing of many complex biochemical processes. Perturbation of this balance may lead to myocardial dysfunction or may be a secondary result of structural heart disease such as myocardial infarction (MI) or cardiomyopathic processes. Altered signaling systems in turn contribute to the progression of myocardial dysfunction. The roles of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in normal and failing myocardium and vasculature have been the subject of intense investigation and continue to engender considerable debate. A disturbance in the oxidation–reduction state of the cell, in which ROS production exceeds antioxidant defenses, is called oxidative stress. By analogy, nitrosative stress is an impairment in nitric oxide (NO) signaling caused by increased amounts of RNS, which may be caused by or associated with a disturbance in the redox state. This review addresses the role of the redox state and nitroso–redox balance in determining cardiovascular function in health and disease.


*    The Chemistry of Nitroso–Redox Balance
 
Free radicals are highly reactive molecules with unpaired electrons. Free radical chemistry is the underpinning of 2 broad classes of signaling molecules in biological systems: ROS, which are reactive intermediates of oxygen metabolism, and a closely related group of RNS. The forms of ROS that are relevant in biological systems include the superoxide radical (O2·), hydrogen peroxide (H2O2), and hydroxyl radical (OH·).1 RNS of biological importance include NO, low- and high-molecular-weight S-nitrosothiols, and peroxynitrite (ONOO)2 (Figure 1).


Figure Removed (Available Only in the Full Text)
View larger version (16K):
[in this window]
[in a new window]
 
Figure 1. Sources of ROS and RNS. Superoxide is produced by a . . . [Full Text of this Article]




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
M.-C. Kuo, D. Patschan, S. Patschan, L. Cohen-Gould, H.-C. Park, J. Ni, F. Addabbo, and M. S. Goligorsky
Ischemia-Induced Exocytosis of Weibel-Palade Bodies Mobilizes Stem Cells
J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2321 - 2330.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. L. Moens, E. Takimoto, C. G. Tocchetti, K. Chakir, D. Bedja, G. Cormaci, E. A. Ketner, M. Majmudar, K. Gabrielson, M. K. Halushka, et al.
Reversal of Cardiac Hypertrophy and Fibrosis From Pressure Overload by Tetrahydrobiopterin: Efficacy of Recoupling Nitric Oxide Synthase as a Therapeutic Strategy
Circulation, May 20, 2008; 117(20): 2626 - 2636.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
E. Braunwald
Biomarkers in Heart Failure
N. Engl. J. Med., May 15, 2008; 358(20): 2148 - 2159.
[Full Text] [PDF]


Home page
Circ. Res.Home page
J. Sun, M. Morgan, R.-F. Shen, C. Steenbergen, and E. Murphy
Preconditioning Results in S-Nitrosylation of Proteins Involved in Regulation of Mitochondrial Energetics and Calcium Transport
Circ. Res., November 26, 2007; 101(11): 1155 - 1163.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
E. M. Redout, M. J. Wagner, M. J. Zuidwijk, C. Boer, R. J.P. Musters, C. van Hardeveld, W. J. Paulus, and W. S. Simonides
Right-ventricular failure is associated with increased mitochondrial complex II activity and production of reactive oxygen species
Cardiovasc Res, September 1, 2007; 75(4): 770 - 781.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. A. Kass, E. Takimoto, T. Nagayama, and H. C. Champion
Phosphodiesterase regulation of nitric oxide signaling
Cardiovasc Res, July 15, 2007; 75(2): 303 - 314.
[Abstract] [Full Text] [PDF]